Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by blocking the use of estrogen by the tumor cells or by lowering the amount of estrogen the body makes. PURPOSE: This phase II trial is studying how well letrozole works in treating women with ductal carcinoma in situ.

Key facts

Study ID
NCT01439711
Run by
Alliance for Clinical Trials in Oncology
People needed
108
Starts
2012-02-01
Expected to finish
2018-01-01
Last updated by the study team
2018-03-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.